{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:06:13Z","timestamp":1788951973240,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.clbc.2026.07.025","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:43:06Z","timestamp":1784763786000},"page":"114-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dynamic Changes in NPAR and the CALLY Score for Predicting Pathological Complete Response in Breast Cancer: A Simple Combined Clinical Score"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5721-9550","authenticated-orcid":false,"given":"B\u00fcnyamin","family":"G\u00fcney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zg\u00fcr","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semih","family":"Sa\u011f\u0131r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ba\u015fak","family":"\u00c7ak\u0131r G\u00fcney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didar","family":"\u015eenocak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u0131za Umar","family":"G\u00fcrsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clbc.2026.07.025_bib0001","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"10.1016\/j.clbc.2026.07.025_bib0002","first-page":"1355","article-title":"Pathologic complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival","volume":"6","author":"Spring","year":"2020","journal-title":"JAMA Oncol"},{"issue":"15","key":"10.1016\/j.clbc.2026.07.025_bib0004","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","article-title":"Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in breast cancer","volume":"30","author":"von Minckwitz","year":"2012","journal-title":"J Clin Oncol"},{"issue":"9938","key":"10.1016\/j.clbc.2026.07.025_bib0005","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet"},{"issue":"10286","key":"10.1016\/j.clbc.2026.07.025_bib0006","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","article-title":"Breast cancer","volume":"397","author":"Loibl","year":"2021","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.clbc.2026.07.025_bib0007","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa1814017","article-title":"Trastuzumab emtansine for residual invasive HER2-positive breast cancer","volume":"380","author":"von Minckwitz","year":"2019","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.clbc.2026.07.025_bib0008","first-page":"1813","article-title":"Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy","volume":"20","author":"Marinovich","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"15","key":"10.1016\/j.clbc.2026.07.025_bib0009","first-page":"1719","article-title":"Locally advanced breast cancer: MRI for prediction of response to neoadjuvant chemotherapy","volume":"30","author":"Hylton","year":"2012","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.clbc.2026.07.025_bib0010","first-page":"1834","article-title":"Accuracy of ultrasonography and mammography in predicting pathologic complete response after neoadjuvant chemotherapy for breast cancer","volume":"17","author":"Keune","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.clbc.2026.07.025_bib0011","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.clbc.2026.07.025_bib0012","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.clbc.2026.07.025_bib0013","first-page":"e179","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis","volume":"15","author":"Templeton","year":"2014","journal-title":"Lancet Oncol"},{"issue":"16","key":"10.1016\/j.clbc.2026.07.025_bib0014","first-page":"5730","article-title":"Prognostic value of neutrophil-to-platelet-albumin ratio in patients with hepatocellular carcinoma","volume":"9","author":"Huang","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.clbc.2026.07.025_bib0015","article-title":"Prognostic value of neutrophil-to-platelet-albumin ratio in pancreatic cancer","volume":"11","author":"Yang","year":"2021","journal-title":"Front Oncol"},{"issue":"27","key":"10.1016\/j.clbc.2026.07.025_bib0016","first-page":"43760","article-title":"Prognostic significance of neutrophil-to-platelet-albumin ratio in gastrointestinal cancers","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.clbc.2026.07.025_bib0017","first-page":"488","article-title":"The CALLY index predicts prognosis in patients with hepatocellular carcinoma","volume":"28","author":"Iida","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2026.07.025_bib0018","first-page":"1701","article-title":"The C-reactive protein\/albumin ratio as a prognostic indicator in patients with hepatocellular carcinoma","volume":"35","author":"Kinoshita","year":"2015","journal-title":"Anticancer Res"},{"issue":"2","key":"10.1016\/j.clbc.2026.07.025_bib0019","first-page":"286","article-title":"Clinical significance of inflammation-based prognostic scores in gastric cancer patients","volume":"20","author":"Toyokawa","year":"2017","journal-title":"Gastric Cancer"},{"issue":"22","key":"10.1016\/j.clbc.2026.07.025_bib0020","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/jnci\/djr393","article-title":"Assessment of Ki67 in breast cancer: recommendations from the International Ki67 Working Group","volume":"103","author":"Dowsett","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"28","key":"10.1016\/j.clbc.2026.07.025_bib0021","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1200\/JCO.2007.10.6823","article-title":"Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy","volume":"25","author":"Symmans","year":"2007","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.clbc.2026.07.025_bib0022","first-page":"e394","article-title":"Tumor regression grade after neoadjuvant chemotherapy in breast cancer","volume":"16","author":"Denkert","year":"2015","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.clbc.2026.07.025_bib0023","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1200\/JCO.2014.58.1967","article-title":"Tumor-infiltrating lymphocytes and prognosis in breast cancer treated with neoadjuvant chemotherapy","volume":"33","author":"Denkert","year":"2015","journal-title":"J Clin Oncol"},{"issue":"47","key":"10.1016\/j.clbc.2026.07.025_bib0024","first-page":"82661","article-title":"Dynamic changes in inflammatory markers during cancer treatment and their prognostic significance","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.clbc.2026.07.025_bib0025","article-title":"Change in inflammatory biomarkers and survival outcomes in cancer patients","volume":"108","author":"Templeton","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2026.07.025_bib0026","first-page":"64","article-title":"Prognostic value of systemic inflammation-based markers in locally advanced rectal cancer","volume":"135","author":"Topkan","year":"2019","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2026.07.025_bib0027","first-page":"449","article-title":"Prognostic significance of inflammation-based prognostic scores in patients with gastric cancer","volume":"23","author":"Hirahara","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.clbc.2026.07.025_bib0028","first-page":"69","article-title":"Inflammatory biomarkers and lung cancer prognosis","volume":"20","author":"Tomita","year":"2014","journal-title":"Ann Thorac Cardiovasc Surg"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926001278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926001278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:07:09Z","timestamp":1788948429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820926001278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1526820926001278"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2026.07.025","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dynamic Changes in NPAR and the CALLY Score for Predicting Pathological Complete Response in Breast Cancer: A Simple Combined Clinical Score","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2026.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}